Complexes of specific presynaptic proteins have been hypothesized to drive or catalyze the membrane fusion steps of exocytosis. Here we use a stage-specific preparation to test the roles of SNAREs, synaptotagmin, and SNARE-binding proteins in the mechanism of Ca 2؉ -triggered membrane fusion. Excess exogenous proteins, sufficient to block SNARE interactions, did not inhibit either the Ca 2؉ sensitivity, extent, or kinetics of fusion. In contrast, despite a limited effect on SNARE and synaptotagmin densities, treatments with high doses of chymotrypsin markedly inhibited fusion. Conversely, low doses of chymotrypsin had no effect on the Ca 2؉ sensitivity or extent of fusion but did alter the kinetic profile, indicating a more direct involvement of other proteins in the triggered fusion pathway. SNAREs, synaptotagmin, and their immediate binding partners are critical to exocytosis at a stage other than membrane fusion, although they may still influence the triggered steps.
potheses (5) (6) (7) (8) . This model suggests that the SNARE proteins (VAMP/synaptobrevin, syntaxin, and SNAP-25) interact to form a heterotrimeric core complex consisting of a 4-stranded helical bundle (7, 9, 10) , which is proposed to "zipper-up," and thereby drive or catalyze the fusion of apposed membranes. These interactions are modeled to be necessary and sufficient for membrane fusion. However, other evidence suggests that the SNARE proteins are not the minimal, essential machinery required for Ca 2ϩ -triggered fusion of native membranes (11) (12) (13) (14) (15) and instead indicate that SNAREs function at a critical stage of exocytosis that is upstream of membrane fusion. Postulated critical upstream roles for the SNAREs in exocytosis include (i) membrane targeting and initial attachment (16, 17) , (ii) the modulation of Ca 2ϩ sensitivity for the triggering steps of exocytosis (11, 15, 18) , and (iii) the regulation of Ca 2ϩ channels (19 -22) .
Analysis of a fundamental molecular mechanism, such as Ca 2ϩ -triggered fusion, is most efficiently carried out in a stagespecific native preparation; sea urchin egg cortical vesicles (CV) provide such a stage-specific model of Ca 2ϩ -triggered membrane fusion (11, 12, 15, 18) . By effectively isolating the triggered steps of fusion from the other concurrent and overlapping stages of the exocytotic pathway, this system permits rigorous coupling of the functional and biochemical analyses necessary to effectively dissect this molecular mechanism (11, 15, 18) . This preparation allows access to the entire membrane surface of CV, ameliorating issues of access to essential proteins at fully docked sites. In addition, CV contain defined homologues of the SNARE proteins and synaptotagmin (23) , consistent with their essential, conserved roles during exocytosis. Using established methods, including blockade of protein interactions (8, 24 -27) and protease treatments (15) , the analysis presented here firmly places the roles of identified SNARE interactions at a stage of exocytosis upstream of triggered membrane fusion.
EXPERIMENTAL PROCEDURES

Preparation of Recombinant Proteins
Syntaxin 1A (NCB accession number NP_446240; residues 1-267), syntaxin 1A "open" (residues 1-267) (28, 29) , syntaxin 1B (NCB accession number B48213; residues 1-266), VAMP2 (NCB accession number NP_036795; residues 1-135), SNAP-23c (NCB accession number NP_003816; residues 134 -211), SNAP-25 (NCB accession number NP_112253; residues 1-206), SNAP-29c (NCB accession number NP_004773; residues 184 -258), synaptotagmin I (NCB accession number P21707; residues 77-421), nSec1 (NCB accession number AAA19246; residues 1-594), and cysteine string protein (NCB accession numbers AAA81372; residues 1-198) are glutathione S-transferase (GST) fusion proteins. ␣ 1B II-III linker peptide of N-type Ca 2ϩ channel (NCB accession number NP_671482; residues 718 -963) is a His 6 fusion protein. The constructs and fusion proteins (without transmembrane regions) were expressed and isolated as described previously (29 -31) . The purity of recombinant SNAREs and SNARE-binding proteins identified in Table I (49 -86%) was determined as described previously (32) . Mock transfections and isolations of expressed GST and His 6 were carried out, and these isolates were used as background controls during functional assays. * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 
Preparation of CV Suspensions
CV were isolated, purified, and counted as described previously (11) . All experiments were carried out in base-line intracellular media supplemented with 2.5 mM ATP and protease inhibitors (11, 15) .
In Vitro Binding Assay
The capacity of endogenous CV SNAREs to bind the recombinant proteins was assessed as described previously (29) . CV membrane proteins were extracted by the methods described for rat brain homogenate (29) and incubated with the recombinant proteins bound to glutathione or nickel beads; bound CV SNAREs were identified by SDS-PAGE and high sensitivity immunoblotting (32) .
CV Treatments
SNARE Blocking Experiments-Based upon protein concentration (DC protein assay kit, Bio-Rad), the measured protein purities using Coomassie Brilliant Blue R stain (32) , and the average density (ϩ1 S.E.) of CV VAMP (6710 copies/CV) (32), the various recombinant proteins were added to CV suspensions at Ն75-100-fold molar excess relative to endogenous VAMP (ϳ1200 -1600-fold excess over endogenous syntaxin). To permit full access and binding of the exogenous and endogenous CV proteins, these suspensions were incubated for 1 h at 25°C prior to assessment of fusion (end-point or kinetic assays). Affinity purified polyclonal antibodies against the cytoplasmic domain of sea urchin synaptotagmin (1:100 dilution), sea urchin VAMP (1:100) (23), and rat syntaxin 1A (1:200; Stressgen Biotechnologies Corp., Victoria, BC) were similarly tested for effects on function.
Chymotrypsin Treatments-Chymotrypsin treatments of 400 units were carried out as described previously for other broad spectrum proteases (1 h, 25°C) (15) . Chymotrypsin treatments of 50 units were carried out for 40 min at 25°C. Following these treatments, CV were recovered and resuspended in base-line intracellular media supplemented with 2.5 mM ATP; final suspensions also contained 2 M L-1-tosylamido-2-phenylethyl chloromethyl ketone (Sigma) in addition to the standard mixture of protease inhibitors used during the preparation of CV suspensions (11, 15) .
Fusion Assays-Standard end-point fusion assays and data analysis were carried out as described (11, 15) , using the Wallac VICTOR 2 V 1420 multilabel HTS plate reader (PerkinElmer Life Sciences). Each condition was tested in sets of 3-5 repeats per experiment; data are reported as mean Ϯ S.E. Curves were fit using SigmaPlot ® (2001 for Windows) to establish the extent and Ca 2ϩ sensitivity (EC 50 ) of fusion. Kinetic assays were carried out essentially as described for end-point assays, with the exception that optical density measurements were made at successive 150-or 250-ms intervals after the rapid injection of buffer containing 200 Ϯ 27 M [Ca 2ϩ ] free (injection time of 140 ms for 50 l using the WALLAC 1420 -251 liquid injector). Two-sample, twotailed t-tests were performed to determine differences of end-point and kinetic parameters between the experimental conditions.
Western Blotting-CV proteins were isolated by organic precipitation using 1:1 acetone:ethanol (12) . SDS-PAGE, electrotransfer, and immunoblotting were carried out essentially as described (32) , with the exception that blots were blocked with 5% skim milk/PBST (0.05% Tween 20 in phosphate-buffered saline) solution and developed using the ECLϩplus Western blotting detection system (Amersham Biosciences). Protein bands were visualized using Kodak Biomax Light film or digitized directly using the PerkinElmer ProXPRESS proteomic imaging system and quantified by densitometric analysis using ImageQuant software (Amersham Biosciences).
RESULTS
As expected for such highly conserved, essential proteins (23) (urchin and rat SNAREs are ϳ70 -90% homologous, including the coiled-coil regions necessary for SNARE interactions), recombinant SNAREs, and other presynaptic SNAREbinding proteins also bind to the native CV membrane SNAREs (Fig. 1A) . Urchin syntaxin binds to the recognized syntaxin binding partners VAMP2, SNAP-25, synaptotagmin, nSec1, and cysteine string protein; selectivity is confirmed by the lack of syntaxin binding to recombinant SNAP23c and SNAP-29c (Fig. 1A, top panel) . Urchin VAMP binds to syntaxin 1A, rat VAMP2, and synaptotagmin (Fig. 1A,  bottom panel) . Binding of all three exogenous SNAREs to the CV membrane prior to fusion assays was also confirmed (inset, Fig. 1B) . As in other systems (8, 24 -27) , recombinant SNAREs and SNARE-binding proteins were therefore used to block endogenous SNARE interactions (both cis and trans). The Ca 2ϩ sensitivity and extent of fusion were not significantly different between buffer controls (EC 50 ϭ 19.0 Ϯ 1.2 M and extent ϭ 96.5 Ϯ 2.2% fusion; n ϭ 22) and background controls (GST and His 6 , see Table I ). Data for each blocking experiment were normalized and compared with a parallel GST or His 6 background control.
At Ͼ85-fold molar excess (relative to VAMP, the most abundant CV SNARE (32)), neither syntaxin 1A, SNAP-25, nor VAMP2 had a significant effect on the extent or Ca 2ϩ sensitivity of triggered fusion compared with parallel controls (Fig. 1B and Table I ). These exogenous SNAREs also had no significant effect on the peak rate of fusion when challenged with 200 Ϯ 27 M [Ca 2ϩ ] free (Fig. 1C , Table II) 1.4 Ϯ 0.2% fusion) had no effect (n ϭ 2 each). An alternate assay format (11) showed no evidence for an effect of exogenous proteins on the ability of CV to contact one another (not shown). Disrupting any pre-existing cis SNARE complexes using Ca 2ϩ pretreatments (12) to ensure full access of the exogenous proteins to the CV SNAREs also had no effect on the Ca 2ϩ sensitivity or extent of fusion (not shown). Other presynaptic proteins with established SNARE binding capacities (27, 31, (33) (34) (35) (36) were also tested for possible effects on the Ca 2ϩ -triggered step(s) of fusion (at Ն75 times molar excess) (Table I) including (i) ␣ 1B II-III linker region of N-type Ca 2ϩ channel (the synprint peptide, that is known to bind urchin syntaxin (37)) (Table I) ; (ii) a combination of syntaxin 1A and nSec1 (⌬EC 50 ϭ 3.5 M and ⌬extent ϭ 0% fusion; n ϭ 1); and (iii) affinity purified polyclonal antibodies against urchin synaptotagmin (⌬EC 50 ϭ 1.6 Ϯ 0.6 M and ⌬extent ϭ 4.5 Ϯ 4.1% fusion; n ϭ 3), urchin VAMP (⌬EC 50 ϭ 2.1 M and ⌬extent ϭ 0% fusion; n ϭ 1), and rat syntaxin 1A (⌬EC 50 ϭ 1.1 M and ⌬extent ϭ 0% fusion; n ϭ 1); none of these exogenous peptides, proteins, or antibodies significantly affected the extent or Ca 2ϩ sensitivity of the triggered fusion steps.
To remove proteins critical to fusion, a protease treatment paradigm (15) was applied to free-floating, non-contacting CV in suspension. This pretreatment with the serine protease chymotrypsin (400 units) significantly inhibited the extent of subsequent Ca 2ϩ -triggered fusion by ϳ80% (n ϭ 8; Fig. 2A ). However, this substantial inhibition of fusion occurred despite limited effects on total SNARE densities; 52 Ϯ 3%, 53 Ϯ 1%, and 33 Ϯ 5% syntaxin, SNAP-25, and VAMP, respectively, remained following the chymotrypsin treatment (inset, Fig.  2A) . If the SNAREs are essential to fusion, the SNARE densities remaining after chymotrypsin treatment should be sufficient to support full fusion (15, 38) . As syntaxin is the limiting native SNARE at ϳ330 syntaxin/CV (32), then ϳ172 syntaxin/CV (ϳ52 syntaxin/m 2 ) remain after chymotrypsin treatment, easily fulfilling the estimated need for three syntaxincontaining complexes/release site (38) ; ϳ1800 VAMP/CV (ϳ550 VAMP/m 2 ) and ϳ380 SNAP-25/CV (ϳ115 SNAP-25/m 2 ) also remained after treatment. Yet fusion is all but abolished following the treatments with chymotrypsin. Conversely, treatment of CV with 50 units of chymotrypsin does not decrease extent of fusion nor alter Ca 2ϩ sensitivity (⌬EC 50 ϭ 1.5 M; n ϭ 4) (Fig. 2B ) but does significantly reduce the peak rate of fusion from 17.1 Ϯ 4.5%/s to 2.4 Ϯ 0.9%/s (n ϭ 4) (Fig. 2C) , despite a limited effect on SNARE densities; 52 Ϯ 7%, 64 Ϯ 3%, and 47 Ϯ 3% syntaxin, SNAP-25, and VAMP, respectively, remained following treatment by 50 units of chymotrypsin. In addition, synaptotagmin is not substantially affected by chymotrypsin treatment (82 Ϯ 6%; n ϭ 4 remained following treatment by 50 or 400 units). The altered kinetic profile of CV fusion suggests an alternate chymotrypsin target that is closer to the fusion step than are the SNAREs.
DISCUSSION
By all available criteria, fully primed and release-ready CV are "locked" at a step in the exocytotic pathway that is downstream of critical SNARE interactions but immediately preceding Ca 2ϩ triggering (11, 12, 18) ; essentially, this is equivalent to the rapidly (immediately) releasable pool of vesicles in neuroendocrine cells (39, 40) . Even after removal from their docking sites on the plasma membrane, isolated CV remain primed A, treatment of CV with 400 units of chymotrypsin (E; n ϭ 8) substantially inhibits fusion relative to parallel controls (q). Inset, quantitative immunoblotting reveals a limited effect of chymotrypsin on the density of CV SNAREs. B, treatment of CV with 50 units of chymotrypsin (f) does not alter the extent or Ca 2ϩ sensitivity of fusion relative to parallel controls (Ⅺ; n ϭ 4). C, treatment with 50 units of chymotrypsin (n ϭ 4; E) substantially alters the kinetic profile of fusion relative to parallel controls (F).
and fully fusion-competent, in the absence of cytosolic factors (11, 12, 15, 18) . As any decrease in the density of a protein essential to triggered fusion is expected to inhibit the rate of fusion (41, 42) , we tested the roles of different presynaptic proteins in the Ca 2ϩ -triggered steps of fusion by reducing their effective concentrations (and thus critical interactions) with excess recombinant binding partners. Although SNAP-25 naturally lacks a transmembrane domain and therefore may still functionally interact with native SNAREs when added exogenously, this may be less likely as the recombinant lacks the acyl modifications necessary for membrane anchoring. There were no effects on the rate, Ca 2ϩ sensitivity, or extent of triggered fusion; protease treatments directly confirmed the dissociation of fusion from SNARE densities (Fig. 2) (15) . We have previously shown that fusion (at maximal [Ca 2ϩ ] free ) is independent of CV syntaxin density (15) . Here we show that fusion kinetics can be altered despite limited changes in SNARE protein densities. The differential effects of chymotrypsin doses on function but minimal effects on synaptotagmin densities confirm the results of the blocking experiments with recombinant synaptotagmin ( Fig. 1 and Table I ) and synaptotagmin antibodies, suggesting that synaptotagmin is not essential to the fusion mechanism. Thus, despite isolation from their fully docked state at the plasma membrane, CV do not require additional or repeated intermembrane SNARE interactions to support Ca 2ϩ -triggered fusion as rapid as seen in other secretory cell types (15, 40, 42, 43) . In addition, the results argue against synaptotagmin as the Ca 2ϩ sensor for triggered fusion. The data are consistent with the hypothesis presented by Voets et al. (43) , suggesting that synaptotagmin influences the transition of a vesicle into the readily releasable pool; such a function would already have occurred in the population of fully release-ready CV.
Although not clearly defined, the state of readiness established by intermembrane SNARE binding in vivo or of SNARE interactions with other identified presynaptic proteins outlasts the actual physical interactions of these proteins. Although essential to exocytosis as a whole (determined by the use of clostridial toxins (44) ), at pre-fusion steps, these functions are not essential to the actual molecular interactions that drive the structural rearrangements inherent to membrane merger. The results are therefore most consistent with the notion that other essential proteins function downstream of SNARE interactions to effect the actual triggered membrane fusion step(s) of exocytosis (12, 14, 15) . Thus, considering the data presented here and that from a variety of other (semi)intact secretory cells, intermembrane "zippering" of SNARE complexes does not drive native fusion but may represent the final step of priming, a critical series of reactions enabling subsequent efficient triggered fusion, a function already fulfilled in fully docked and fusion-ready CV. This primed state may be analogous to previously postulated "tight" SNARE complexes (26) ; although this stage can be rapid and transient, as seen in secretory cells undergoing high rates of fusion, it is also clearly separated from the fusion step. Thus, identified presynaptic proteins (Table I), including synaptotagmin, have critical roles elsewhere in the exocytotic pathway, perhaps involving modulation at the plasma membrane docking site.
